Page last updated: 2024-08-24

cidofovir anhydrous and Herpes Zoster, Ocular

cidofovir anhydrous has been researched along with Herpes Zoster, Ocular in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barshak, MB; Durand, ML; Foster, CS; Kim, IK; Mali, JO; Scott, NL; Stryjewski, TP; Tobin, EH; Young, LH1
Mitchell, SM; Obi, AA; Zambarakji, HJ1
Lajusticia, J; Ramos, C1

Other Studies

3 other study(ies) available for cidofovir anhydrous and Herpes Zoster, Ocular

ArticleYear
Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Vitreous Body

2018
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
    Ocular immunology and inflammation, 2002, Volume: 10, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body

2002
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Organophosphonates

2004